MKD News and Press, Molecular Data Inc.

Molecular Data (NASDAQ:MKD) had received a letter from the Nasdaq, notifying the Company that to date, it has not regained compliance with the Rule 5250(c)(1). As the Co. has failed to comply with the $1.00 minimum bid price requirement set forth in Listing Rule 5550(a)(2). For further deta...

Molecular Data Inc. Receives NASDAQ Notification PR Newswire SHANGHAI , June 24, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ: MKD), a technology-driven platform in China , announced that it had received a lett...

Molecular Data Inc. Receives NASDAQ Notification Regarding Minimum Bid Requirements PR Newswire SHANGHAI , May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ( "Molecular Data" or the "Company" ) (NASDAQ: MKD), a technology-driven platform ...

Gainers: GoldMining (GLDG) +25%. Mesa Royalty Trust (MTR) +23%. Origin Agritech (SEED) +17%. ZK International Group Co. (ZKIN) +13%. Alpha Metallurgical Resources (AMR) +12%. Losers: Molecular Data (MKD) -22%. Snow Lake Resources (LITM) -13%. Rayonier Advanced Materials (RYAM) -11%....

Gainers: Lixiang Education Holding (LXEH) +62%. GeoVax Labs (GOVX) +50%. Sonder Holdings (SOND) +30%. O2Micro International (OIIM) +30%. Evolving Systems (OTC:EVOL) +28%. GoldMining (GLDG) +27%. Neonode (NEON) +24%. Mesa Royalty Trust (MTR) +24%. TRxADE HEALTH (MEDS) +23%. Losers: HIVE Blockc...

HIVE Blockchain Technologies (HIVE) -79%. Molecular Data (MKD) -27% on ADS ratio change Evoke Pharma (EVOK) -22% after real-world data analysis reveals a lower risk of Tardive Dyskinesia with metoclopramide. NeuroMetrix (NURO) -9%. Immix Biopharma (IMMX) -7%. For further deta...

Molecular Data (NASDAQ:MKD -25.6%) has announced a ratio change on its ADS from the current one ADS representing three Class A ordinary shares to the new ratio of one ADS representing forty-five Class A ordinary shares. Each ADS holder of record at the close of business on the date when the c...

Molecular Data Inc. Announces ADS Ratio Change PR Newswire SHANGHAI , May 20, 2022 /PRNewswire/ -- Molecular Data Inc. (NASDAQ: MKD) (the "Company") announced today a ratio change on its American Depositary Shares ("ADS") from the current one (1) ADS...

Molecular Data (NASDAQ:MKD) slips 5% PM on receiving non compliance notice from Nasdaq over its delay in filing its annual report on Form 20-F for the period ended December 31, 2021 The Company has 60 calendar days to submit a plan to regain compliance if accepted it will ...

Molecular Data Inc. Announces Receipt of Nasdaq Non-Compliance Letter PR Newswire SHANGHAI , May 20, 2022 /PRNewswire/ -- Molecular Data Inc. (NASDAQ: MKD) (the "Company") announced today that on May 17, 2022 , it received a Delinquency Complianc...